Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30015733HIVENSG00000126267.11protein_codingCOX6B1NoNo1340P14854
TVIS30007487HIVENSG00000126267.11protein_codingCOX6B1NoNo1340P14854
TVIS30018311HIVENSG00000126267.11protein_codingCOX6B1NoNo1340P14854
TVIS30021449HIVENSG00000126267.11protein_codingCOX6B1NoNo1340P14854
TVIS30048554HIVENSG00000126267.11protein_codingCOX6B1NoNo1340P14854
TVIS30048555HIVENSG00000126267.11protein_codingCOX6B1NoNo1340P14854
TCGA Plot Options
Drug Information
GeneCOX6B1
DrugBank IDDB02659
Drug NameCholic Acid
Target IDBE0003995
UniProt IDP14854
Regulation Type
PubMed IDs10592235
CitationsBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
GroupsApproved
Direct ClassificationTrihydroxy bile acids, alcohols and derivatives
SMILES[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
PathwaysCongenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX)
PharmGKBPA166160055
ChEMBLCHEMBL205596